Posting of 2025 Annual Report and Notice of AGM

Creo Medical Group plc (AIM: CREO), the medical device company specialising in advanced energy solutions for therapeutic endoscopy, announces that the Annual Report and Accounts for the year ended 31 December 2025 and the Notice of the Company's Annual General Meeting ("AGM") have now been published on the Company's website at https://www.creomedical.com/en/investors/reports-and-presentations. Hard copies have been posted to those shareholders who have not elected to receive electronic communication from the Company.

The AGM will be held on 29 June 2026 at 10:00 a.m. at the offices of Osborne Clarke LLP at Halo, Counterslip, Bristol BS1 6AJ, and will consider the Resolutions set out in the Notice of AGM. The Company's CEO, Craig Gulliford, will make a short presentation at the meeting. No new material information will be included within the presentation.

Shareholders are encouraged to vote by proxy at the AGM, which can be done:

• by completing, signing the Form of Proxy and returning it to Equiniti; or
• in the case of CREST members, by utilising the CREST electronic proxy appointment service.

Proxy votes must be received no later than 10:00 a.m. on 25 June 2026. All voting at the AGM will be conducted by a poll. Shareholders are recommended to appoint the Chair of the meeting as their proxy rather than a named person, as any such other person may not be permitted to attend the AGM in the event of unforeseen circumstances (e.g. illness).